Pilot RCT of early respiratory infection prevention in intubated patients

Phase 4, randomised trial of ceftriaxone in pneumonia, tracheobronchitis and pulmonary infection (3 arms), sponsored by Hospital Clínico San Carlos. Primary endpoints: Incidence of severe adverse events related to devices, antibiotic, and infection and Incidence of respiratory tract infections. Planned start May 2025; status: authorised.